Clazosentan in Preventing the Occurrence of Cerebral Vasospasm Following an Aneurysmal Subarachnoid Hemorrhage (aSAH) "CONSCIOUS-1"

Completed

Phase 2 Results

Summary of Purpose

The purpose of the study is to measure how effective and safe three different doses of the drug clazosentan are in preventing vasospasm after subarachnoid hemorrhage.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 October 2017.

10 Jan 2005 17 May 2005 30 Mar 2006 30 Mar 2006 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available